Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The association between levels of tissue inhibitor of metalloproteinase-1 with acute heart failure and left ventricular dysfunction in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention

Monika Pavkova Goldbergova, Jiri Parenica, Jiri Jarkovsky, Petr Kala, Martin Poloczek, Jan Manousek, Krystyna Kluz, Lenka Kubkova, Simona Littnerova, Martin Tesak, Ondrej Toman, Nikolas Pavek, Zdenka Cermakova, Josef Tomandl, Anna Vasku, Jindrich Spinar

. 2012 ; 16 (10) : 1172-1178.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024312

Grantová podpora
NS9894 MZ0 CEP - Centrální evidence projektů

AIMS: Tissue inhibitors of metalloproteinase (TIMPs) bind to active matrix metalloproteinase (MMPs), and thereby inhibit their proteolytic activity. We investigated the role of polymorphisms in the gene for TIMP-1 and serum levels of TIMP-1 in association with postmyocardial infarction (MI), left ventricular (LV) dysfunction, and symptoms of acute heart failure (AHF) in patients treated with primary percutaneous coronary intervention. METHODS: In total, 556 patients with STEMI were evaluated. Levels of TIMP-1 were measured at admission and 24 h after MI onset. The TIMP-1 exon 5 SNP rs4898 (F124F with T>C) located at X chromosome was assayed. RESULTS: TIMP-1 levels were higher for men with AHF as well as for men with LV dysfunction (ejection fraction [EF]<40%). According to multivariate analysis, the TIMP-1 level was a factor with an independent negative relationship to EF and AHF in men. An independent relationship between exon 5 TIMP-1 gene polymorphism and EF, AHF or TIMP-1 level was not documented. CONCLUSION: These results provide evidence that a higher level of circulating TIMP-1 is independently associated with worse EF and AHF.

000      
00000naa a2200000 a 4500
001      
bmc13024312
003      
CZ-PrNML
005      
20200720084648.0
007      
ta
008      
130703s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/gtmb.2012.0120 $2 doi
035    __
$a (PubMed)22971139
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Goldbergova, Monika Pavkova $u Institute of Pathological Physiology, Masaryk University, Brno, Czech Republic
245    14
$a The association between levels of tissue inhibitor of metalloproteinase-1 with acute heart failure and left ventricular dysfunction in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention / $c Monika Pavkova Goldbergova, Jiri Parenica, Jiri Jarkovsky, Petr Kala, Martin Poloczek, Jan Manousek, Krystyna Kluz, Lenka Kubkova, Simona Littnerova, Martin Tesak, Ondrej Toman, Nikolas Pavek, Zdenka Cermakova, Josef Tomandl, Anna Vasku, Jindrich Spinar
520    9_
$a AIMS: Tissue inhibitors of metalloproteinase (TIMPs) bind to active matrix metalloproteinase (MMPs), and thereby inhibit their proteolytic activity. We investigated the role of polymorphisms in the gene for TIMP-1 and serum levels of TIMP-1 in association with postmyocardial infarction (MI), left ventricular (LV) dysfunction, and symptoms of acute heart failure (AHF) in patients treated with primary percutaneous coronary intervention. METHODS: In total, 556 patients with STEMI were evaluated. Levels of TIMP-1 were measured at admission and 24 h after MI onset. The TIMP-1 exon 5 SNP rs4898 (F124F with T>C) located at X chromosome was assayed. RESULTS: TIMP-1 levels were higher for men with AHF as well as for men with LV dysfunction (ejection fraction [EF]<40%). According to multivariate analysis, the TIMP-1 level was a factor with an independent negative relationship to EF and AHF in men. An independent relationship between exon 5 TIMP-1 gene polymorphism and EF, AHF or TIMP-1 level was not documented. CONCLUSION: These results provide evidence that a higher level of circulating TIMP-1 is independently associated with worse EF and AHF.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x krev $x genetika $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a infarkt myokardu $x krev $x genetika $x terapie $7 D009203
650    _2
$a koronární angioplastika $x metody $7 D062645
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a tkáňový inhibitor metaloproteinasy 1 $x krev $x genetika $7 D019715
650    _2
$a dysfunkce levé srdeční komory $x krev $x genetika $7 D018487
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Parenica, Jiri $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center–Department of Cardiovascular Disease, University Hospital St Anne's, Brno, Czech Republic
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
700    1_
$a Kala, Petr $u -
700    1_
$a Poloczek, Martin $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Manousek, Jan $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kluz, Krystyna $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Cardiology Department, Hospital Podlesi a.s., Třinec, Czech Republic $7 xx0243485
700    1_
$a Kubkova, Lenka $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Littnerova, Simona $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
700    1_
$a Tesak, Martin $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Toman, Ondrej $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Pavek, Nikolas $u Institute of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Cermakova, Zdenka $u Biochemistry Department, University Hospital Brno, Brno, Czech Republic
700    1_
$a Tomandl, Josef $u Institute of Biochemistry, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Vasku, Anna $u Institute of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Spinar, Jindrich $u Cardiology Department, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center–Department of Cardiovascular Disease, University Hospital St Anne's, Brno, Czech Republic
773    0_
$w MED00174670 $t Genetic testing and molecular biomarkers $x 1945-0257 $g Roč. 16, č. 10 (2012), s. 1172-1178
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22971139 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20200720084648 $b ABA008
999    __
$a ok $b bmc $g 987992 $s 822692
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 16 $c 10 $d 1172-1178 $i 1945-0257 $m Genetic testing and molecular biomarkers $n Genet Test Mol Biomarkers $x MED00174670
GRA    __
$a NS9894 $p MZ0
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Možnosti archivace